Therapeutic effects of a new synthetic lipid A analog, ONO-4007, on rat hepatoma KDH-8 depend on tumor necrosis factor-sensitivity of the tumor cells

Anti-Cancer Drugs

Volumn 8, Issue 9, 1997, Pages 898-901

  Kuramitsu, Yasuhiro ^a,b   Matsushita, Kazuhiro ^a   Ohiro, Youichi ^a   Obara, Manabu ^a   Kobayashi, Masanobu ^a   Hosokawa, Masuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatoma; Lipid A; Lipopolysaccharide; Tumor necrosis factor

Indexed keywords

2 DEOXY 3 O (9 PHENYLNONANOYL) 2 [3 (9 PHENYLNONANOYLOXY)TETRADECANOYLAMINO]GLUCOPYRANOSE 4 SULFATE; LIPID A DERIVATIVE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR NECROSIS;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; FEMALE; INDICATORS AND REAGENTS; LIPID A; LIVER NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED STRAINS; RATS, WISTAR; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030696876     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199710000-00012     Document Type: Article

References (12)

1. Morrison DC, Ryan JL. Endotoxins and disease mechanisms. Annu Rev Med 1983; 38: 417-32.
2. Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986; 164: 777-93.
3. Satoh M, Inagawa H, Shimada Y, Soma G, Oshima H, Mizuno D. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin. J Biol Response Mod 1987; 6: 512-24.
4. Yamazaki M, Okutomi T. Augmentation of cytotoxin from murine bone marrow and peritoneal macrophages by tumor transplantation. Cancer Res 1989; 49: 352-6.
5. Kobayashi ,M, Nagayasu H, Hamada J, Takeichi N, Hosokawa M. ONO-4007, a new synthetic lipid A derivative, induces differentiation of rat myelomonocytic leukemia cells in vitro and in vivo. Exp Hematol 1994; 22: 454-9.
6. Kuramitsu Y, Nishibe M, Ohiro Y, et al. A new synthetic lipid A analog, ONO-4007, stimulates the production of TNF-α in tumor tissues, resulting in the rejection of transplanted rat hepatoma cells. Anti-Cancer Drugs 1997; 8: 500-8.
7. Sugiura C, Itaya T, Kondoh N, Oikawa T, et al. Xenogenization of tumor cells by transfection with plasmid containing env gene of Friend leukemia virus. Jpn J Cancer Res 1988; 79: 1259-63.
8. Kueng W, Silber E, Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem 1989; 182: 16-9.
9. Gatanaga T, Noguchi K, Tanabe Y, Inagawa H, Soma G, Mizuno D. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional r-TNF-α in vivo. J Biol Response Mod 1989; 8: 278-86.
10. Koshita Y, Itoh Y, Fujii S, et al. Mechanisms of tumor regression of TNF gene-transduced Meth-A cells transplanted in mice. Ann NY Acad Sci 1994; 716: 334-5.
11. Yang D, Satoh M, Ueda H, Tsukagoshi S, Yamazaki M. Activation of tumor-infiltrating macrophages by a synthetic lipid A analog (ONO-4007) and its implication in antitumor effects. Cancer Immunol Immunother 1994; 38: 287-93.
12. Kuramitsu Y, Ohiro Y, Matsushita K, Obara M, Kobayashi M, Hosokawa M. The mechanism of locally enhanced production of tumor necrosis factor-α in tumor tissues by the administration of a new synthetic lipid A analog, ONO-4007 in hepatoma-bearing rats. Anti-Cancer Drugs 1997; 8: 886-93.